Letter by Groth et al Regarding Article, "Impact of Pathogenic FBN1 (Fibrillin-1) Variant Types on the Progression of Aortic Disease in Patients With Marfan Syndrome"

Circ Genom Precis Med. 2018 Sep;11(9):e002319. doi: 10.1161/CIRCGEN.118.002319.

Authors

Kristian A Groth¹, Claus H Gravholt², Niels H Andersen³

Affiliations

¹ Department of Cardiology, Aarhus University Hospital, Denmark. (K.A.G.).
² Department of Endocrinology and Internal Medicine and Department of Molecular Medicine, Aarhus University Hospital, Denmark. (C.H.G.).
³ Department of Cardiology, Aalborg University Hospital, Denmark (N.H.A.).

PMID: 30354333
DOI: 10.1161/CIRCGEN.118.002319

No abstract available

Publication types

Letter
Comment

MeSH terms

Aortic Diseases*
Disease Progression
Fibrillin-1
Fibrillins
Humans
Marfan Syndrome*

Substances

FBN1 protein, human
Fibrillin-1
Fibrillins